Imaging is an integral part of diagnosis and treatment. Multiparametric MR prostate imaging is primarily done to evaluate the prostate and to identify targets for biopsy. This helps to reduce sampling errors and improve subsequent correct diagnosis and management of prostate cancers. It is called multiparametric imaging as various sequences such as T2W, T1W, DWI, […]
Dr Kiran Lingaraju, Dr Deepak Pai
Diana, Princess of Wales Hospital
Prostate cancer is the most common cancer in men in 112 countries, and its incidence and mortality will have doubled by 2040. Nearly 50% of newly presenting patients in the UK harbour low and intermediate-favourable-risk localised disease, for which active surveillance (AS) offers non-inferior survival outcomes compared to radical treatment. AS involves repeat testing to […]
Dr Nikita Sushentsev
Emmanuel College, University of Cambridge
Since October 2021 cancer networks have been measured against the new Faster Diagnostic Standard (FDS), which states that a patient should have a diagnosis or exclusion of cancer within 28 days from referral. Prostate cancer diagnosis, especially since the universal implementation of multi-parametric MRI (mpMRI), has always been a challenge to the fast-track diagnostic process, […]
Dr Harry Bardgett
Bradford Teaching Hospitals NHS Foundation Trust
Focal therapy for prostate cancer has undergone a renaissance during recent years. The advent and utilisation of high quality multiparametric prostate MRI has meant that a growing number of men are able to have small but suspicious prostate lesions detected and ultimately targeted for biopsy. Undoubtedly the PROMIS and PRECISION trials have played a significant […]
Dr Alex King, Rory Heard
University Hospital Southampton
Multiparametric MRI (mpMRI) has a central role in the prostate cancer (PCa) diagnostic pathway, with its utility now established for clinically significant cancer detection by national and international guidelines. The Prostate Imaging Reporting and Data System (PI-RADS) recommends a standardised approach for mpMRI acquisition and provides a standardised framework for mpMRI interpretation through predefined objective […]
Dr Heminder Kaur Sokhi
Paul Strickland Scanner Centre, Mount Vernon Hospital
Multiparametric prostate MRI (mpMRI) is now established as the gold standard first-line investigation for identifying potentially curative prostate cancer. It is routinely requested for men with a persistently raised PSA blood test (in the absence of a urinary tract infection) and/or concerns identified on a digital rectal examination of the prostate. The threshold for requesting […]
Dr Steven Kennish, Dr Rachel Hubbard
Sheffield Teaching Hospitals NHS Foundation Trust, University College London Hospitals NHS Foundation Trust